v3.25.2

SCHEDULE OF COMMON STOCK UNDERLYING OUTSTANDING WARRANTS (Details) - $ / shares	6 Months Ended	12 Months Ended
	Apr. 30, 2025	Oct. 31, 2024	Oct. 31, 2023
Class of Warrant or Right [Line Items]
Underlying number of shares beginning	261,650	444,454
Average exercise price beginning	$ 26.00	$ 20.56
Weighted average life ending	1 year 14 days	1 year 3 months 21 days	1 year 7 months 24 days
Underlying number of shares ending	215,881	261,650	444,454
Average exercise price ending	$ 26.00	$ 26.00	$ 20.56
Warrants A [Member]
Class of Warrant or Right [Line Items]
Underlying number of shares granted
Average exercise price, granted
Underlying number of shares expirations		(182,804)
Average exercise price, expired		$ 13.00
Warrants B [Member]
Class of Warrant or Right [Line Items]
Underlying number of shares granted
Average exercise price, granted
Underlying number of shares expirations	(45,769)
Average exercise price, expired

Share based compensation, non options expired for weighted average exercise price.

+ References

No definition available.

+ Details

Name:	VTRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredWeightedAverageExercisePrice
Namespace Prefix:	VTRO_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Share based compensation, non options granted for weighted average exercise price.

+ References

No definition available.

+ Details

Name:	VTRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice
Namespace Prefix:	VTRO_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Share based compensation, non options outstanding for weighted average exercise price.

+ References

No definition available.

+ Details

Name:	VTRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix:	VTRO_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Share based compensation, non options for weighted average remaining contractual term.

+ References

No definition available.

+ Details

Name:	VTRO_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageRemainingContractualTerm2
Namespace Prefix:	VTRO_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Net number of non-option equity instruments granted to participants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of equity instruments other than options outstanding, including both vested and non-vested instruments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=VTRO_WarrantsAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=VTRO_WarrantsBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Vitro Biopharma, Inc. 10-Q